Profluent vs Recursion
A side-by-side comparison of Profluent and Recursion, two Science tools, drawn from Ignaite's continuously-verified listings.
Compared from listings verified as of
At a glance
| Attribute | Profluent | Recursion |
|---|---|---|
| Category | Science | Science |
| Pricing | PAID | PAID |
| License | Proprietary | Proprietary |
| Deployment | Cloud | Cloud |
| Platforms | Web | Web |
| Model support (differs) | — | Self-contained (on-device) |
| Vendor (differs) | Profluent Bio | Recursion Pharmaceuticals |
| Capabilities (differs) |
|
|
The honest brief
Profluent
Pairs frontier protein LLMs with openly released designs like OpenCRISPR-1, while most peers keep AI-designed molecules proprietary.
- ProGen protein-LLM lineage
- Open-released gene editor
- Nature-published work
- Eli Lilly and IDT partnerships
- Partnership/licensing only
- No self-serve platform
- Open releases are sequences, not a service
- Opaque pricing
Recursion
Runs a vast in-house automated wet lab generating millions of cell experiments weekly, feeding a 50+ petabyte dataset few rivals can match.
- Recursion OS with LOWE language layer
- Massive proprietary biology dataset
- Natural-language target and compound queries
- Public company with pharma partners
- No self-serve product or API
- Partner and internal use only
- Opaque pricing
- No approved drug yet
When to pick which
Both cover Molecular design.
Pick Profluent if you need Protein design and Antibody design.
- Protein design (primary capability)
- Antibody design (secondary capability)
Pick Recursion if you need Drug target discovery and Autonomous research.
- Drug target discovery (primary capability)
- Autonomous research (secondary capability)